Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Asset Utilization Ratio: 2012-2024

Historic Asset Utilization Ratio for RedHill Biopharma (RDHL) over the last 13 years, with Dec 2024 value amounting to 0.39.

  • RedHill Biopharma's Asset Utilization Ratio rose 69.80% to 0.76 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.76, marking a year-over-year increase of 69.80%. This contributed to the annual value of 0.39 for FY2024, which is 445.31% up from last year.
  • Latest data reveals that RedHill Biopharma reported Asset Utilization Ratio of 0.39 as of FY2024, which was up 445.31% from 0.07 recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Asset Utilization Ratio registered a high of 0.51 during FY2020, and its lowest value of 0.07 during FY2023.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.36 (2022), whereas its average is 0.28.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 449.08% in 2020, then crashed by 80.25% in 2023.
  • Yearly analysis of 5 years shows RedHill Biopharma's Asset Utilization Ratio stood at 0.51 in 2020, then decreased by 6.23% to 0.47 in 2021, then fell by 23.41% to 0.36 in 2022, then crashed by 80.25% to 0.07 in 2023, then surged by 445.31% to 0.39 in 2024.